vs
SciSparc Ltd.（SPRC）与ScanTech AI Systems Inc.（STAI）财务数据对比。点击上方公司名可切换其他公司
ScanTech AI Systems Inc.的季度营收约是SciSparc Ltd.的1.4倍（$631.0K vs $461.0K），ScanTech AI Systems Inc.净利率更高（-1532.9% vs -2041.6%，领先508.8%）
SciSparc Ltd.是一家处于临床阶段的生物制药企业，专注于开发针对神经系统疾病、精神类疾病及胃肠道疾病未被满足医疗需求的创新疗法，依托专有大麻素制剂技术推进多条候选药物管线，面向全球生物医药市场开展相关业务。
SPRC vs STAI — 直观对比
营收规模更大
STAI
是对方的1.4倍
$461.0K
净利率更高
STAI
高出508.8%
-2041.6%
损益表 — Q2 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $461.0K | $631.0K |
| 净利润 | $-9.4M | $-9.7M |
| 毛利率 | 78.1% | 27.6% |
| 营业利润率 | -588.5% | -773.2% |
| 净利率 | -2041.6% | -1532.9% |
| 营收同比 | -45.1% | — |
| 净利润同比 | -155.8% | — |
| 每股收益（稀释后） | $17.92 | $-0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SPRCSTAI
| Q3 25 | — | $631.0K | ||
| Q2 25 | $461.0K | $884.0K | ||
| Q1 25 | — | $346.1K | ||
| Q4 24 | $466.0K | — | ||
| Q2 24 | $840.0K | — | ||
| Q2 23 | $2.0M | — |
净利润SPRCSTAI
| Q3 25 | — | $-9.7M | ||
| Q2 25 | $-9.4M | $-6.9M | ||
| Q1 25 | — | $-17.9M | ||
| Q4 24 | $-3.8M | — | ||
| Q2 24 | $-3.7M | — | ||
| Q2 23 | $-2.9M | — |
毛利率SPRCSTAI
| Q3 25 | — | 27.6% | ||
| Q2 25 | 78.1% | 14.3% | ||
| Q1 25 | — | 29.4% | ||
| Q4 24 | 6.9% | — | ||
| Q2 24 | 56.4% | — | ||
| Q2 23 | 74.2% | — |
营业利润率SPRCSTAI
| Q3 25 | — | -773.2% | ||
| Q2 25 | -588.5% | -440.1% | ||
| Q1 25 | — | -4503.9% | ||
| Q4 24 | -813.1% | — | ||
| Q2 24 | -419.9% | — | ||
| Q2 23 | -150.5% | — |
净利率SPRCSTAI
| Q3 25 | — | -1532.9% | ||
| Q2 25 | -2041.6% | -785.1% | ||
| Q1 25 | — | -5174.2% | ||
| Q4 24 | -813.9% | — | ||
| Q2 24 | -438.0% | — | ||
| Q2 23 | -148.7% | — |
每股收益（稀释后）SPRCSTAI
| Q3 25 | — | $-0.16 | ||
| Q2 25 | $17.92 | $-0.16 | ||
| Q1 25 | — | $-0.77 | ||
| Q4 24 | $-8.82 | — | ||
| Q2 24 | $35.70 | — | ||
| Q2 23 | $10.85 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.5M | — |
| 总债务越低越好 | — | $17.7M |
| 股东权益账面价值 | $-81.0K | — |
| 总资产 | $5.1M | $5.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SPRCSTAI
| Q3 25 | — | — | ||
| Q2 25 | $1.5M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.5M | — | ||
| Q2 24 | $252.0K | — | ||
| Q2 23 | $2.1M | — |
总债务SPRCSTAI
| Q3 25 | — | $17.7M | ||
| Q2 25 | — | $17.7M | ||
| Q1 25 | — | $17.7M | ||
| Q4 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
股东权益SPRCSTAI
| Q3 25 | — | — | ||
| Q2 25 | $-81.0K | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.9M | — | ||
| Q2 24 | $8.7M | — | ||
| Q2 23 | $6.8M | — |
总资产SPRCSTAI
| Q3 25 | — | $5.1M | ||
| Q2 25 | $5.1M | $4.6M | ||
| Q1 25 | — | $5.1M | ||
| Q4 24 | $10.3M | — | ||
| Q2 24 | $10.5M | — | ||
| Q2 23 | $9.9M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.9M | $-758.5K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流SPRCSTAI
| Q3 25 | — | $-758.5K | ||
| Q2 25 | $-1.9M | $-1.5M | ||
| Q1 25 | — | $-2.2M | ||
| Q4 24 | $-2.9M | — | ||
| Q2 24 | $-2.2M | — | ||
| Q2 23 | $-3.2M | — |
自由现金流SPRCSTAI
| Q3 25 | — | — | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-2.2M | ||
| Q4 24 | — | — | ||
| Q2 24 | $-2.2M | — | ||
| Q2 23 | — | — |
自由现金流率SPRCSTAI
| Q3 25 | — | — | ||
| Q2 25 | — | -166.0% | ||
| Q1 25 | — | -623.8% | ||
| Q4 24 | — | — | ||
| Q2 24 | -261.7% | — | ||
| Q2 23 | — | — |
资本支出强度SPRCSTAI
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | — | ||
| Q2 24 | 0.1% | — | ||
| Q2 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
